Peer-reviewedCC BYCurrent issues in molecular biology
Brain Blindness Versus Eye Blindness: Genetic and Molecular Connections Between Alzheimer’s Disease and Visual Impairment
- 1College of BioNano Technology, , Seongnam 13120, Republic of Korea;
- 2Department of Bionano Technology, Gachon Medical Research Institute, , Seongnam 13120, Republic of Korea
Related
- Exploring the Neuroprotective Effects of Walnut (Juglans regia L.) Against Cognitive Impairment in Alzheimer’s Disease Through the MAPK-mTORC1-TFEB-Mediated Endolysosomal Pathway: A Network Pharmacology and Molecular Docking Approach
- Genetic Risk Architecture of Late-Onset Alzheimer’s Disease: Mapping Single-Nucleotide Polymorphisms to Disease-Defining Molecular Pathways
- Luteolin for Alzheimer's disease and related cognitive impairment: a systematic review and meta-analysis of efficacy and molecular mechanisms.
- Integrative Genetic and Transcriptomic Analysis Reveals Candidate Molecular Differences Among Dementia with Lewy Bodies, Alzheimer’s Disease, and Parkinson’s Disease Dementia
- Genetic and Environmental Connections Shared between Transmissible Liability to Substance Use Disorder and Substance Use Initiation
BibTeX
@article{bagyinszky2026brain,
title = {{Brain Blindness Versus Eye Blindness: Genetic and Molecular Connections Between Alzheimer’s Disease and Visual Impairment}},
author = {Eva Bagyinszky and Seong Soo A. An},
journal = {Current issues in molecular biology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13703017},
note = {CC BY},
}
RIS
TY - JOUR
TI - Brain Blindness Versus Eye Blindness: Genetic and Molecular Connections Between Alzheimer’s Disease and Visual Impairment
AU - Eva Bagyinszky
AU - Seong Soo A. An
PY - 2026
DA - 2026/10/01
JO - Current issues in molecular biology
UR - https://europepmc.org/article/PMC/PMC13703017
SN - 1467-3037
SN - 1467-3045
ER -